Journal Article
|Commentary

Focusing on quality patient care in the new global subsidy for malaria medicines


Abstract
Tido von Schoen-Angerer and colleagues discuss the new Affordable Medicines Facility for malaria (AMFm), which subsidizes and facilitates access to artemisinin-based combination therapy, and what mechanisms are needed to ensure it stays focused on quality patient care.

Languages

English